BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Events for Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220629
DTEND;VALUE=DATE:20220701
DTSTAMP:20260503T142958
CREATED:20220621T123709Z
LAST-MODIFIED:20220621T123709Z
UID:3263-1656460800-1656633599@abliva.com
SUMMARY:Bioblast 2022: Inaugural Conference of Bioenergetics Communications
DESCRIPTION:On June 29-30\, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck\, Austria. \nAbliva’s Communications Officer & Lab Manager\, Eleonor Åsander Frostner\, will present a summary of the company’s recent preprint publication “Towards a treatment for mitochondrial disease: current compounds in clinical development“.
URL:https://abliva.com/event/bioblast-2022-inaugural-conference-of-bioenergetics-communications/
LOCATION:Congress Innsbruck\, Rennweg 3\, Innsbruck\, Austria
CATEGORIES:Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/06/Innsbruck.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220608
DTEND;VALUE=DATE:20220612
DTSTAMP:20260503T142958
CREATED:20220608T114247Z
LAST-MODIFIED:20220608T114247Z
UID:3245-1654646400-1654991999@abliva.com
SUMMARY:UMDF's Mitochondrial Medicine Symposium
DESCRIPTION:Abliva will participate at the United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium in Phoenix\, Arizona. \nAbliva’s CMO\, Magnus Hansson\, will participate in a panel discussion on clinical trials together with Baylor College of Medicine\, Cyclerion Therapeutics\, and Khondrion\, on Friday June 10.
URL:https://abliva.com/event/umdfs-mitochondrial-medicine-symposium/
LOCATION:JW Marriott Phoenix Desert Ridge Resort & Spa\, Phoenix\, AZ\, United States
CATEGORIES:Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/06/Phoenix_Arizona.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220222
DTEND;VALUE=DATE:20220225
DTSTAMP:20260503T142958
CREATED:20211111T134348Z
LAST-MODIFIED:20211111T134348Z
UID:2973-1645488000-1645747199@abliva.com
SUMMARY:Mitochondria-Targeted Drug Development Summit
DESCRIPTION:Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston\, MA\, USA. The event will be held on 22 – 24 February 2022. \nCEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease. \nSynopsis: \n\nHighlighting the impact of patient input on research and development at Abliva\nProviding an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva\nPresenting placebo controlled PMD patient data from our lead asset\, KL1333
URL:https://abliva.com/event/mitochondria-targeted-drug-development-summit/
LOCATION:Hyatt Regency Boston/Cambridge\, 575 Memorial Dr\, Cambridge\, Massachusetts\, 02139\, United States
CATEGORIES:Scientific event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211130
DTEND;VALUE=DATE:20211203
DTSTAMP:20260503T142958
CREATED:20211111T130531Z
LAST-MODIFIED:20211122T145635Z
UID:2970-1638230400-1638489599@abliva.com
SUMMARY:Mitochondrial Medicine - Therapeutic Development
DESCRIPTION:Abliva will attend the virtual conference Mitochondrial Medicine – Therapeutic Development\, organized by the Wellcome Connecting Science located at the Wellcome Genome Campus in the UK\, on 30 Nov – 2 Dec 2021. \nAbliva’s CMO\, Magnus Hansson\, has been invited to give a presentation on the topic Academia-pharma interplay in drug development\, during Session 1: Mitochondrial Medicine – pharma and funding perspectives.
URL:https://abliva.com/event/mitochondrial-medicine-therapeutic-development/
LOCATION:Virtual
CATEGORIES:Scientific event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211015
DTEND;VALUE=DATE:20211017
DTSTAMP:20260503T142958
CREATED:20211011T131302Z
LAST-MODIFIED:20211011T131302Z
UID:2916-1634256000-1634428799@abliva.com
SUMMARY:Mitochondrial Diseases Conference 2021
DESCRIPTION:Italian patient organization Mitocon arranges this year’s Mitochondrial Diseases Conference in virtual. \nAbliva’s Chief Medical Officer\, Magnus Hansson\, will give a flash presentation and join round table discussions at the meeting.
URL:https://abliva.com/event/mitochondrial-diseases-conference-2021/
LOCATION:Virtual
CATEGORIES:Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2021/10/Girls-heart_big.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210624
DTEND;VALUE=DATE:20210627
DTSTAMP:20260503T142958
CREATED:20210524T104537Z
LAST-MODIFIED:20210524T104758Z
UID:2775-1624492800-1624751999@abliva.com
SUMMARY:UMDF Mitochondrial Medicine
DESCRIPTION:The US patient organization United Mitochondrial Disease Foundation (UMDF) is hosting its annual Mitochondrial Medicine Symposium\, this year virtual\, in June. \nAbliva will participate in the scientific sessions: \n\nChief Medical Officer\, Magnus Hansson\, will constitute one of the panelists\, on Friday 25 June\, at 1:50 p.m. EST\, in the Clinical Trials Panel #2 Discussion\, together with representatives from Baylor College of Medicine\, Cyclerion Therapeutics\, and Khondrion.\nData from Abliva’s Phase 1a/b study with KL1333 will be presented on an e-Poster\, available to registered participants throughout the event.
URL:https://abliva.com/event/umdf-mitochondrial-medicine/
LOCATION:Virtual
CATEGORIES:Scientific event
END:VEVENT
END:VCALENDAR